UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Annals of oncology, 2012-09, Vol.23 (9), p.2313-2318

2012

Volltextzugriff (PDF)

The role of chemotherapy in the landscape of liposarcoma

Annals of oncology, 2018-10, Vol.29, p.viii594-viii594

2018

Volltextzugriff (PDF)

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Annals of oncology, 2017-11, Vol.28 (11), p.2906-2906

2017

Volltextzugriff (PDF)

Molecular characterization and pharmacological profile of myxofibrosarcoma primary cultures

Annals of oncology, 2017-10, Vol.28, p.vi66-vi66

2017

Volltextzugriff (PDF)

Bone health management in early breast cancer patients: an Italian Osteoncology Center experience

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi25-vi26

2017

Volltextzugriff (PDF)

Corrections to “Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?”

Annals of oncology, 2017-11, Vol.28 (11), p.2906-2906

2017

Volltextzugriff (PDF)

Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results

The quarterly journal of nuclear medicine and molecular imaging, 2015-12, Vol.59 (4), p.400

2015

Volltextzugriff (PDF)

2607 Predicting venous thromboembolism (VTE) in metastatic urothelial tract tumors (UTT)

European journal of cancer (1990), 2015-09, Vol.51, p.S514-S514

2015

Volltextzugriff (PDF)

2619 Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)

European journal of cancer (1990), 2015-09, Vol.51, p.S518-S518

2015

Volltextzugriff (PDF)

2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients

European journal of cancer (1990), 2015-09, Vol.51, p.S496-S496

2015

Volltextzugriff (PDF)

Study of inter-fraction variability of absorbed dose to bone metastases and follow-up for a patient who underwent 223Ra-dichloride therapy

Physica medica, 2016-02, Vol.32, p.100-101

2016

Volltextzugriff (PDF)

Clinical and Molecular Determinants of Survival in Pancreatic Cancer Patients Treated with Second-line Chemotherapy: Results of an Italian/Swiss Multicenter Survey

Anticancer research, 2010-10, Vol.30 (10), p.4289-4295

2010

Volltextzugriff (PDF)

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

OncoTargets and therapy, 2016-01, Vol.9, p.6233-6246

2016

Volltextzugriff (PDF)

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

Annals of oncology, 2021-09, Vol.32, p.S1004-S1005

2021

Volltextzugriff (PDF)

1660P The promising role of the extracellular matrix in the activity of trabectedin in soft tissue sarcoma: A prospective study on a UPS and L-sarcoma patient-derived primary culture case series using 3D and zebrafish models

Annals of oncology, 2020-09, Vol.31, p.S988-S988

2020

Volltextzugriff (PDF)

1170P The prognostic role of DLL3 expression in high-grade gastroenteropancreatic neuroendocrine neoplasms

Annals of oncology, 2020-09, Vol.31, p.S776-S776

2020

Volltextzugriff (PDF)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

OncoTargets and therapy, 2017-01, Vol.10, p.1155-1164

2017

Volltextzugriff (PDF)

1660PThe role of chemotherapy in the landscape of liposarcoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Metastatic neuroendocrine neoplasia (mNEN) treatments in over 70 years (y) old patients: A retrospective outcome analysis

Annals of oncology, 2017-09, Vol.28, p.v151-v152

2017

Volltextzugriff (PDF)

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model

Journal of bone oncology, 2019-06, Vol.16, p.100227-100227, Article 100227

2019

Volltextzugriff (PDF)

Retrospective analysis of the efficacy of somatostatin analogs (SSA) in metastatic pulmonary neuroendocrine tumors and prognostic significance of FDG-PET

Annals of oncology, 2016-10, Vol.27, p.vi144-vi144

2016

Volltextzugriff (PDF)

Recombinant granulocyte colony-stimulating factors (rG-CSFs) in the management of NEUtropenia induced by anthracyclines and ifosfamide in patients with soft tissue SARcomas (NEUSAR)

Annals of oncology, 2016-09, Vol.27, p.iv99

2016

Volltextzugriff (PDF)

Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model

Annals of oncology, 2016-09, Vol.27, p.iv117

2016

Volltextzugriff (PDF)

2121 Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US)

European journal of cancer supplements, 2009, Vol.7 (2), p.174-174

2009

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(25)
Female
(16)
Middle Aged
(16)
Adult
(14)
Oncology
(14)
Male
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Aged
(8)
Retrospective Studies
(7)
Tumors
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Metastasis
(5)
Old Medline
(5)
Animals
(4)
Cancer
(4)
Carcinoma, Transitional Cell - Drug Therapy
(4)
Hematology, Oncology And Palliative Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

The role of chemotherapy in the landscape of liposarcoma

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Molecular characterization and pharmacological profile of myxofibrosarcoma primary cultures

Bone health management in early breast cancer patients: an Italian Osteoncology Center experience

Corrections to “Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?”

Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results

2607 Predicting venous thromboembolism (VTE) in metastatic urothelial tract tumors (UTT)

2619 Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)

2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients

Study of inter-fraction variability of absorbed dose to bone metastases and follow-up for a patient who underwent 223Ra-dichloride therapy

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer

Clinical and Molecular Determinants of Survival in Pancreatic Cancer Patients Treated with Second-line Chemotherapy: Results of an Italian/Swiss Multicenter Survey

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

1660P The promising role of the extracellular matrix in the activity of trabectedin in soft tissue sarcoma: A prospective study on a UPS and L-sarcoma patient-derived primary culture case series using 3D and zebrafish models

1170P The prognostic role of DLL3 expression in high-grade gastroenteropancreatic neuroendocrine neoplasms

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

1660PThe role of chemotherapy in the landscape of liposarcoma

Metastatic neuroendocrine neoplasia (mNEN) treatments in over 70 years (y) old patients: A retrospective outcome analysis

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model

Retrospective analysis of the efficacy of somatostatin analogs (SSA) in metastatic pulmonary neuroendocrine tumors and prognostic significance of FDG-PET

Recombinant granulocyte colony-stimulating factors (rG-CSFs) in the management of NEUtropenia induced by anthracyclines and ifosfamide in patients with soft tissue SARcomas (NEUSAR)

Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model

2121 Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US)

Suchergebnisse filtern